| Judith Michelle Mayer, MD | |
|
5333 Mcauley Drive, Suite 4003, Ypsilanti, MI 48197-1099 | |
| (734) 712-3470 | |
| (734) 712-2935 |
| Full Name | Judith Michelle Mayer |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 24 Years |
| Location | 5333 Mcauley Drive, Ypsilanti, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215997309 | NPI | - | NPPES |
| 4416225-10 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 4301079689 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fmc Dialysis - Adrian | Adrian, MI | Dialysis facility |
| Fmc - East Ann Arbor Home Dialysis | Ann arbor, MI | Dialysis facility |
| St Joseph Mercy Hospital | Ann arbor, MI | Hospital |
| Emma L Bixby Medical Center | Adrian, MI | Hospital |
| St Joseph Mercy Chelsea | Chelsea, MI | Hospital |
| Saint Joseph Mercy Livingston Hospital | Howell, MI | Hospital |
| Promedica Monroe Regional Hospital | Monroe, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nephrology Associates Of Michigan Pc | 8729136486 | 21 |
News Archive
Soligenix, Inc., a clinical stage biopharmaceutical company, announced today that the Food and Drug Administration has completed its review and cleared the Investigational New Drug application for SGX942 for the treatment of oral mucositis resulting from radiation and/or chemotherapy treatment in head and neck cancer patients.
The Association of Clinical Research Organizations (ACRO), which represents the global leaders in clinical outsourcing, today released the following statement in recognition of World Heart Day.
In an effort to determine if stem cell therapy can prevent or improve a condition called "diabetic foot" caused by poor blood flow in patients with diabetes, a team of researchers in China has found that transplanting human placenta-derived mesenchymal stem cells (MSCs) into rats modeled with diabetes can affect blood vessel growth, potentially improving blood flow and preventing critical limb ischemia (CLI), a condition that results in diabetic foot and frequently leads to amputation.
Scientists have identified a gene that appears to play a significant role in raising a person's risk of having more severe subtypes of autism that co-occur with other genetic diseases, such as the chromosomal disorder 22q11.2 deletion syndrome.
› Verified 7 days ago
| Entity Name | Nephrology Associates Of Michigan Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922249366 PECOS PAC ID: 8729136486 Enrollment ID: O20090507000050 |
News Archive
Soligenix, Inc., a clinical stage biopharmaceutical company, announced today that the Food and Drug Administration has completed its review and cleared the Investigational New Drug application for SGX942 for the treatment of oral mucositis resulting from radiation and/or chemotherapy treatment in head and neck cancer patients.
The Association of Clinical Research Organizations (ACRO), which represents the global leaders in clinical outsourcing, today released the following statement in recognition of World Heart Day.
In an effort to determine if stem cell therapy can prevent or improve a condition called "diabetic foot" caused by poor blood flow in patients with diabetes, a team of researchers in China has found that transplanting human placenta-derived mesenchymal stem cells (MSCs) into rats modeled with diabetes can affect blood vessel growth, potentially improving blood flow and preventing critical limb ischemia (CLI), a condition that results in diabetic foot and frequently leads to amputation.
Scientists have identified a gene that appears to play a significant role in raising a person's risk of having more severe subtypes of autism that co-occur with other genetic diseases, such as the chromosomal disorder 22q11.2 deletion syndrome.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Judith Michelle Mayer, MD 5333 Mcauley Drive, Suite 4003, Ypsilanti, MI 48197-1099 Ph: (734) 712-3470 | Judith Michelle Mayer, MD 5333 Mcauley Drive, Suite 4003, Ypsilanti, MI 48197-1099 Ph: (734) 712-3470 |
News Archive
Soligenix, Inc., a clinical stage biopharmaceutical company, announced today that the Food and Drug Administration has completed its review and cleared the Investigational New Drug application for SGX942 for the treatment of oral mucositis resulting from radiation and/or chemotherapy treatment in head and neck cancer patients.
The Association of Clinical Research Organizations (ACRO), which represents the global leaders in clinical outsourcing, today released the following statement in recognition of World Heart Day.
In an effort to determine if stem cell therapy can prevent or improve a condition called "diabetic foot" caused by poor blood flow in patients with diabetes, a team of researchers in China has found that transplanting human placenta-derived mesenchymal stem cells (MSCs) into rats modeled with diabetes can affect blood vessel growth, potentially improving blood flow and preventing critical limb ischemia (CLI), a condition that results in diabetic foot and frequently leads to amputation.
Scientists have identified a gene that appears to play a significant role in raising a person's risk of having more severe subtypes of autism that co-occur with other genetic diseases, such as the chromosomal disorder 22q11.2 deletion syndrome.
› Verified 7 days ago
Bretton Lee Schloesser, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5301 E Huron River Dr, Ypsilanti, MI 48197 Phone: 734-712-8676 | |
Dr. Kelly Perry Apple, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 5301 E Huron River Dr, Ypsilanti, MI 48197 Phone: 734-712-8676 Fax: 734-712-3855 | |
Rajiv Doddamani, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 4001, Ypsilanti, MI 48197 Phone: 734-834-4270 | |
Dr. James Paolo Purtell, MD Nephrology Medicare: Medicare Enrolled Practice Location: 5333 Mcauley Dr, Suite 2111, Ypsilanti, MI 48197 Phone: 734-712-5552 | |
Kory Ashton Strong, DO Nephrology Medicare: Medicare Enrolled Practice Location: Iha Hospital Medicine Services, 5301 E Huron River Drive, Ypsilanti, MI 48197 Phone: 734-712-8676 | |
Michael Sanson, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5361 Mcauley Dr, Ypsilanti, MI 48197 Phone: 734-712-1300 Fax: 734-222-3665 | |
Dr. Stephanie Joy-kraftson Hoffman, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: Iha Hematology Oncology, 5303 Elliott Drive, Suite 210, Ypsilanti, MI 48197 Phone: 734-712-1000 Fax: 734-712-1012 |